VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

Go back to VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
(NASDAQ: VIVS) Delayed: 0.46 +0.01 (2.22%)
Previous Close $0.45    52 Week High
Open $0.43    52 Week Low
Day High $0.48    P/E N/A 
Day Low $0.43    EPS
Volume 2,643,491